CN101928710B - Anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides, recombinant expression and application - Google Patents

Anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides, recombinant expression and application Download PDF

Info

Publication number
CN101928710B
CN101928710B CN 200910053692 CN200910053692A CN101928710B CN 101928710 B CN101928710 B CN 101928710B CN 200910053692 CN200910053692 CN 200910053692 CN 200910053692 A CN200910053692 A CN 200910053692A CN 101928710 B CN101928710 B CN 101928710B
Authority
CN
China
Prior art keywords
lys
ala
rhipilin
anticoagulation
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 200910053692
Other languages
Chinese (zh)
Other versions
CN101928710A (en
Inventor
周金林
石磊
周勇志
李庄
向飞宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Veterinary Research Institute CAAS
Original Assignee
Shanghai Veterinary Research Institute CAAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Veterinary Research Institute CAAS filed Critical Shanghai Veterinary Research Institute CAAS
Priority to CN 200910053692 priority Critical patent/CN101928710B/en
Publication of CN101928710A publication Critical patent/CN101928710A/en
Application granted granted Critical
Publication of CN101928710B publication Critical patent/CN101928710B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention provides an anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides and a recombination expression method applied in escherichia coli. The method comprises the steps of cloning a full-length coding gene of an anticoagulation molecule Rhipilin-1 from the Rhipicephalus haemaphysaloides by creating a salivary glands subtractive library before and after bloodsucking of the Rhipicephalus haemaphysaloides and sequencing analysis, wherein the full length of the nucleotide is 620bp, open reading frame codes 164 amino acid residues, the prospected molecular weight is 18kDa, N-end is provided with a signal peptide sequence formed by 18 amino acids and contain a typical Kunitz functional domain, and the tissue channel inhibiting factor of one of the molecule and the anticoagulation molecule is obviously homologous. The gene is coned to a pGEX-4T-1 expression vector, converted to a BL21 (DE3) host fungus. Through IPTG induction, GST fusion protein is recombined so as to efficiently express in a soluble way. A test for plasma recalcification time and partial thrombin activating time by using purified recombined protein proves that the Rhipilin-1 molecule has anticoagulation bioactivity and can be used for preparing anticoagulation biologic preparation.

Description

The gene order of a kind of anticoagulation molecule Rhipilin-1 of crescent fan head tick and recombinant expressed and application
Technical field
The present invention relates to biotechnology, be specifically related to blood biological gene sequence, recombinant expressed and the application in preparation anti-freezing preparation of Rhipilin-1 gene in intestinal bacteria of crescent fan head tick anticoagulation molecule Rhipilin-1.
Background technology
In the organic evolution process, the blood coagulation system that Mammals has formed a complicacy stops the loss of blood, and often has the coagulation function of a lot of anticoagulant proteins with the antagonism host in the organism of much making a living with blood.Tick is one type of vermin of making a living to suck blood.Compare with other HAEMATOPHAGOUS ARTHROPODS, the time of sucking blood of tick is long especially, as the time of sucking blood of hard tick 10-14 days (Sonenshine, 1993).The process of sucking blood for a long time of tick must cause a series of hemostasis reactions of host, like vasoconstriction, platelet aggregation and blood coagulation.Suck blood for what continue; Tick must overcome host's hemostasis reaction, and since Waxman (1990) identified the anticoagulation molecule of first tick, the researchist found that the sialisterium of tick secrete the multiple anti-hemostasis molecule of generation in the process of sucking blood; The PGD2 of tick salivary gland secretion and I2 can shrink and inhibition platelet aggregation (Bowman by induction of vascular; 1995), several kinds of platelet aggregation arrestin molecules are also identified (Mans, 2002) from hard tick and soft ticks; Anticoagulation molecule to blood coagulation; Like zymoplasm (thrombin) arrestin molecule, factor Xa (FXa) arrestin molecule and tissue factor path arrestin molecule (TFPI) in multiple external advantage tick bodies such as lone star tick, Dermacentor variabilis, a prominent hard tick, Rhipicephalus appendicularis, boophilus microplus, come to light (Maritz-Olivier, 2007).Although the tick anticoagulant molecule of having reported is kind more than 20 nearly, identify fully also seldom, the gene order that obtains these protein moleculars of coding is no more than 8.From present interpretation of result; Tick anticoagulant molecule majority belongs to Kunitz family serinase specificity and suppresses molecule; Characteristic contains the cysteine residues of 1 or 2 KU structure function territories and high conservative, maybe be from same ancestors (Lai, 2004) on evolving.
Because human health in the popular feeling, cerebrovascular disease serious threat that thrombus causes, the anti-bolt preparation of available is limited at present, and therefore, the research of medicine for treating thrombus thing is the field of very paying close attention to (Bates and Weitz, 2006) always.Hirudin has been applied to clinical medicine (Turk, 2006 according to leech (leech) anticoagulation molecule synthetic anticoagulant peptides; Bates and Weitz, 2006).In the tick anticoagulant molecule of having identified; Have 2 molecules in animal model experiment, to have the antithrombotic therapy effect, wherein the TAP molecule identified is factor Xa (FXa) suppressor factor nineteen ninety, and recombinant expressed TAP has shown good anti thrombotic action on a plurality of animal models; Owing to reasons such as antigenicity also fail on the human clinical, to use (Bates and Weitz at present; 2006), but utilize structure and the mechanism of action design of TAP molecule littler, do not have antigenic medicine for treating thrombus thing, perhaps make up novel reorganization medicine for treating thrombus thing molecule and study and make progress; For example; Use TAP functional zone sequence and new reorganization anticoagulant protein molecule of anchorin Annexin V sequence construct, its antithrombotic acitivity improves 10 times (Chen, 2005) than the activity of single anchorin Annexin V.Another tick anticoagulant molecule I xolaris is in recent years from a molecule that prominent hard tick is identified, with people's anatomic passages supressor (TFPI) homology; Anticoagulant factor VIIa/tissue factor complex body; In rat model, very strong anti thrombotic action (Monteiro, 2005 have been shown; Nazareth, 2006).These researchs show that the anticoagulation molecule of tick possibly be developed as novel antithrombotic reagent.
The crescent Rh mainly is distributed in South Asia and southern china in hard tick, is advantage tick kind, at multiple animals such as ox, sheep, dog, the rabbit parasitism of sucking blood, also can attack human body and bite and suck blood, but also not see the research report about its anticoagulation molecule.
Summary of the invention
Technical problem to be solved by this invention is to study crescent fan head tick anticoagulation molecule, development of new anticoagulation biotechnological formulation.
The invention provides the gene order of crescent fan head tick anticoagulation molecule Rhipilin-1, the nucleotide sequence and the corresponding amino acid sequence of its gene are following:
The nucleotide sequence of crescent fan head tick anticoagulation molecule Rhipilin-1:
aatattggaa aaacttcagc gagcagaaaa caaccaaagg caatgaagat tttacaatac 60
gcgctcttgg cttgtcttct cgtctcgata ttaggcgatg atgatgacga agaaaacgag 120
ggtgcggcgg ggagtgatga tgcgggcgca acgcctacag cactgtcgaa gccagcagcc 180
acttctgcgg aaggaaacac cgcagcaaaa aactcaggtg gtgacatcaa gcaaccgaaa 240
caagaactgc ccgaaccgtc ctcaaaaggc caaaagaaac cgagactacc caagagatgc 300
ttattcaagc cagaacaggg aaactgcgca ggttctcgtt tccttcctag atggtggtat 360
aacccagaaa ctgagagctg cgaaccattc acttatccag tgtgcaataa gaaaaacgaa 420
gcattcgtat catgtacact gtgcatgaac atgtgcatga ggaataagag gggcagggag 480
aaggctaaat ggattagaaa agtttgtaga aaaagtccga aagtaaaatc tggatgaatg 540
tagttggctc tgccacttct tctgccataa aatattcgaa aacatttgtt atgaataata 600
aaattatcaa aaaaaaaaaa 620
Crescent fan head tick tick anticoagulant molecule Rhipilin-1 aminoacid sequence
Met Lys Ile Leu Gln Tyr Ala Leu Leu Ala Cys Leu Leu Val Ser Ile
1 5 10 15
Leu Gly Asp Asp Asp Asp Glu Glu Asn Glu Gly Ala Ala Gly Ser Asp
20 25 30
Asp Ala Gly Ala Thr Pro Thr Ala Leu Ser Lys Pro Ala Ala Thr Ser
35 40 45
Ala Glu Gly Asn Thr Ala Ala Lys Asn Ser Gly Gly Asp Ile Lys Gln
50 55 60
Pro Lys Gln Glu Leu Pro Glu Pro Ser Ser Lys Gly Gln Lys Lys Pro
65 70 75 80
Arg Leu Pro Lys Arg Cys Leu Phe Lys Pro Glu Gln Gly Asn Cys Ala
85 90 95
Gly Ser Arg Phe Leu Pro Arg Trp Trp Tyr Asn Pro Glu Thr Glu Ser
100 105 110
Cys Glu Pro Phe Thr Tyr Pro Val Cys Asn Lys Lys Asn Glu Ala Phe
115 120 125
Val Ser Cys Thr Leu Cys Met Asn Met Cys Met Arg Asn Lys Arg Gly
130 135 140
Arg Glu Lys Ala Lys Trp Ile Arg Lys Val Cys Arg Lys Ser Pro Lys
145 150 155 160
Val Lys Ser Gly
Sialisterium subtractive library before and after the present invention sucks blood through the female tick of structure crescent fan head tick carries out the end sequencing analysis to all clones, obtains 247 effective est sequences altogether.To the clone of one of them anticoagulation molecule homologous genes, carried out complete sequence determination and bioinformatic analysis, find that it is complete encoding sox, called after Rhipilin-1 gene.This full length gene is 620bp, holds the signal sequence AATAAAA that polyA and polyA are arranged 3 ', and containing has a complete ORFs, from the 43rd base to 536 base, and 164 amino acid of encoding, predicted molecular weight is 18kDa.The protein signal peptide analysis, the signal peptide sequence that has 18 amino acid to constitute at the N-end; The protein function domain analysis is a typical serpin Kunitz domain at 139 amino acid of the 84th amino acid to the.Blast analyzes the remarkable homology of anatomic passages supressor of finding one of this molecule and anticoagulation molecule.
Another object of the present invention has provided the recombinant expression method of said crescent fan head tick anticoagulation molecule Rhipilin-1 in intestinal bacteria.
According to crescent fan head tick anticoagulation molecule Rhipilin-1 gene biological information science analytical results; With the actual coding district subclone that does not comprise signal peptide sequence in prokaryotic expression carrier pGEX-4T-1; Make up recombinant expression plasmid pGEX-4T-1/Rhipilin-1; After being transformed into BL21 (DE3) expression bacterium, use the IPTG abduction delivering.The SDS-PAGE electrophoretic analysis shows that the reorganization gst fusion protein obtains to efficiently express, and the GST-fusion rotein is 44kDa, big or small consistent with the expection recombinant protein, and further analysis revealed, the recombination fusion protein majority exists with the soluble proteins form.
Another purpose of the present invention has provided the application of said crescent fan head tick anticoagulation molecule Rhipilin-1 in preparation anticoagulation biotechnological formulation.
The present invention is with the crescent fan head tick anticoagulation molecule Rhipilin-1 recombinant protein of purifying; Carry out rabbit plasma recalcification time (Recalcification Time; RT) and partial prothrombinase activationary time (Activated PartialThromboplastin Time; APTT) experiment has confirmed that this molecule has anticoagulant active.
Description of drawings
The nucleotide sequence and the corresponding amino acid sequence analysis of Fig. 1 crescent fan head tick anticoagulation molecule Rhipilin-1 gene
Wherein ATG is an initiator codon; Under to draw the solid line sequence be signal peptide sequence; Arrow is the cleavage site of signal peptide; Under to draw the dotted line sequence be the Kunitz domain; TAG is a terminator codon; AATAAA is a tailing signal.
Expression and the purifying of Fig. 2 crescent fan head tick anticoagulation molecule reorganization Rhipilin-1
M is standard molecular weight albumen; 1 and 2 are respectively and contain before the empty carrier bacteria-induction and induce the back protein band, 3 and 4 be respectively contain protein band before the recombinant vectors bacteria-induction, induce after protein band; 5,6,7 be respectively insoluble protein, soluble proteins and the purified recombinant albumen of inducing bacterium
Fig. 3 crescent fan head tick anticoagulation molecule reorganization Rhipilin-1 blood plasma recalcification time experimental result
A is contrast GST albumen (concentration 18.75~300nM); B is a saline water; C, d, e, f, g are respectively the reorganization Rhipilin-1 sample that concentration is 18.75nM, 37.5nM, 75nM, 150nM, 300nM
Fig. 4 crescent fan head tick anticoagulation molecule reorganization Rhipilin-1 influences 1 for contrasting GST albumen (concentration 15.625~250nM) to rabbit plasma partial prothrombinase activationary time; 2 is saline water; 3,4,5,6,7 be respectively the reorganization Rhipilin-1 sample that concentration is 15.625nM, 31.25nM, 62.5nM, 125nM, 250nM
Embodiment
Gene clone and the sequential analysis of embodiment 1 crescent fan head tick anticoagulation molecule Rhipilin-1
1. materials and methods
1.1 laboratory animal: the crescent fan head tick picks up from the Hubei buffalo, is preserved by this laboratory breeding.New zealand white rabbit is available from Chinese Academy of Sciences's Shanghai Experimental Animal Center.
1.2 test strain, plasmid and reagent: coli strain DH5 α is available from vast Imtech, and plasmid pGEM-TEasy, T4DNA ligase enzyme are available from Promega company, and plasmid pGEX-4T-1 is available from Amersham PharmaciaBiotech; TRIZOL reagent is available from Invitrogen company; DNA glue reclaims test kit available from match Parkson company; Taq archaeal dna polymerase, DNA Marker are available from TaKaRa company; PCR SelectTM cDNA SubtractionKit, SMART PCR cDNA Synthesis Kit, PCR Purification Kit is the Clontech Company products.
1.3 the preparation of crescent fan head tick sialisterium
The crescent fan head tick is not sucked blood into tick by 1: 1 combined inoculation rabbit ear of male and female, and the female tick of half-full blood is taken out in inoculation back 4-5 days, and anatomical lens separates sialisterium down, and-70 ℃ of preservations are subsequent use; Same tick crowd does not suck blood the sialisterium of female tick by separating with quadrat method.
1.4 the extraction of the total RNA of tick sialisterium
Adopt the Trizol reagent of Invitrogen company, press the description of test operation, extract crescent fan head tick do not suck blood female tick and the total RNA of the female tick of half-full blood respectively, be dissolved in the water of no RNase, the mensuration total rna concentration, it is subsequent use to be stored in-70 ℃ of refrigerators then.
1.5 double-stranded cDNA's is synthetic
Adopt the SMART PCR cDNA Synthesis Kit of Clontech company; Be template with total RNA respectively; With Olig (dT) 18 primers synthetic first chain cDNA (ss cDNA) under the effect of M MLV reversed transcriptive enzyme, and with long range PCR (LD-PCR) amplification cDNA second chain (ds cDNA);
1.6 inhibition subtractive hybridization
Use Clontech PCR SelectTM cDNA Subtraction Kit.This test is Tester with the female tick sialisterium of half-full blood, and female tick sialisterium is not Driver to suck blood; Step is following: respectively Adaptor1-Tester cDNA and Adaptor 2R-Tester cDNA are mixed with Driver cDNA, 68 ℃ of incubation 8h carry out the 1st and take turns hybridization; Above-mentioned two reaction product are mixed, and add the Driver cDNA of capacity once more, 68 ℃ are spent the night, and carry out the 2nd and take turns hybridization; Product to subtractive hybridization carries out the two-wheeled pcr amplification, does contrast with the cDNA that adds the female tick of half-full blood that joint not subdues respectively.The primer sequence of PCR is corresponding to the sequence (Clontech PCR SelectTM cDNA Subtraction Kit) of Adaptor 1 and Adaptor 2R.
1.7 the foundation of subtractive library, the screening of positive colony, est sequence are measured and are analyzed
Subtractive hybridization product behind the pcr amplification is through PCR Purification Kit purifying; Be connected with the pGEM-T-easy carrier; Be transformed into competent cell DH5 α and screen blue hickie, picking is the white clone all, increases with nest-type PRC primer Primer 1 and Primer 2R; Positive colony is served the order-checking of sea base health biotech company, and sequencing result carries out homology analysis (http://www.ncbi.nlm.nih.gov/BLAST) on GenBank;
1.8 the full-length gene order of anticoagulation molecule Rhipilin-1 is measured and is analyzed
According to est sequence information, select one and be numbered 48 est sequence, carry out complete sequence determination and bioinformatic analysis, the result is complete coding anticoagulation molecule homologous genes, called after Rhipilin-1 gene.
2. result and analysis
The sialisterium subtractive library successfully made up before and after the female tick of crescent fan head tick was sucked blood, and all clones are carried out the end sequencing analysis, obtained 247 effective est sequences altogether.To the clone of one of them anticoagulation molecule homologous genes, carried out complete sequence determination and bioinformatic analysis, be found to be complete encoding sox, called after Rhipilin-1 gene.This full length gene is 620bp; The signal sequence AATAAAA that polyA and polyA are arranged at 3 ' end; Contain a complete ORFs is arranged; From the 43rd base to 536 base, 164 amino acid of encoding, predicted molecular weight is 18kDa; Protein signal peptide analysis (http://www.cbs.dtu.dk/services/SignalP/) finds to have at the N-end signal peptide sequence of 18 an amino acid formation, and protein function domain analysis (http://smart.embl-heidlberg.de/smart/job_status.) finds at the 84th base to 139 a base place one typical serpin Kunitz domain is arranged.Blast analyzes the remarkable homology of anatomic passages supressor of finding one of this molecule and anticoagulation molecule.
Recombinant expressed and the anticoagulant active checking of embodiment 2 crescent fan head tick anticoagulation molecule Rhipilin-1 genes
1. materials and methods
1.1 laboratory animal: new zealand white rabbit is available from Chinese Academy of Sciences's Shanghai Experimental Animal Center.
1.2 test strain, plasmid and reagent: coli strain DH5 α, BL21 (DE3) are available from vast Imtech, and plasmid pGEM-T Easy, T4DNA ligase enzyme are available from Promega company, and plasmid pGEX-4T-1 is available from Amersham Pharmacia Biotech; DNA glue reclaims test kit available from match Parkson company; Taq archaeal dna polymerase, DNA Marker, EcoRI and Xhol restriction endonuclease are available from TaKaRa company.GSTBind TMTest kit is available from Novagen; The APTT test kit is purchased in sun Bioisystech Co., Ltd; BCA analysis of protein test kit is the PIERCE Company products; Primer is synthetic by match Parkson company.
1.3 the construction of recombinant expression plasmid of crescent fan head tick anticoagulation molecule Rhipilin-1 gene
According to crescent fan head tick anticoagulation molecule Rhipilin-1 gene biological information science analytical results, in prokaryotic expression carrier pGEX-4T-1, upstream primer is with the actual coding district subclone that does not comprise signal peptide sequence:
5 '
Figure G2009100536925D00081
GATGATGATGACGAAGAAAACGAG3 ' downstream primer is:
5 ' TCATCCAGATTTTACTTTCGGACT3 '; 5 ' end and 3 ' end are introduced EcoRI and Xhol I restriction enzyme site respectively; Tilted letter is represented restriction enzyme site, is the protectiveness base in the square frame.With recombinant cloning vector pGEM/Rhipilin-1 is that template is carried out pcr amplification; This program is: behind 94 ℃ of 2min, and with 94 ℃ of 45s, 53 ℃ of 45s, after 72 ℃ of 60s circulation 30 times, last 72 ℃ are extended 10min.With the PCR product reclaim, enzyme is cut, purifying; Simultaneously carrier pGEX-4T-1 is made double digestion with corresponding enzyme; The PCR product of enzyme being cut the back purifying is connected with carrier; Transform DH5 α, cut the positive bacterium colony of evaluation, press the recombinant plasmid pGEX-4T-1/Rhipilin-1 of test kit specification sheets operation extracting positive bacteria through PCR and enzyme;
1.4 the recombinant expressed and purifying of crescent fan head tick anticoagulation molecule Rhipilin-1
To BL21 (DE3), 37 ℃, 200r/min shaking culture are as bacterium liquid OD600 during in 0.6~0.8 left and right sides with recombinant plasmid transformed; In substratum, add IPTG, making final concentration is 1mmol/L, after continuing to cultivate 4h; Centrifugal collection thalline; With 12%SDS-PAGE electrophoretic analysis protein expression situation, reorganization GST amalgamation and expression albumen is used GSTBind TMThe test kit purifying, the BCA method is surveyed protein concentration.
1.5 crescent fan head tick anticoagulation molecule reorganization Rhipilin-1 is to the influence of rabbit plasma recalcification time
Added 3.8% Trisodium Citrate with healthy experimental rabbit whole blood according to 9: 1, the centrifugal 5min of 3000r/min processes in the rabbit Trisodium Citrate blood plasma.In 96 orifice plates, add 0.1mL blood plasma to be measured respectively, add the reorganization Rhipilin-1 sample that 0.1mL is dissolved in the different concns of saline water then, sample and saline water carry out doubling dilution (final concentration is 0.15nm/mL-2.4nm/mL).37 ℃ of insulation 15min; The CaCl that adds 0.1mL 0.025mol/L 2Solution in the 405nm place, whenever in the 0-10min is measured an OD value at a distance from 25s, and the increase of OD value reflects the blood plasma degree of condensing.Contrast adds the saline water and the GST albumen of same volume respectively.Three multiple holes are done in each experiment.
1.6 crescent fan head tick anticoagulation molecule reorganization Rhipilin-1 adds blood plasma 0.1mL to be measured to the influence test of rabbit partial prothrombinase activationary time the Rhipilin-1 of 0.1mL gallogen partial thromboplastin solution and 0.1mL different concns; Hatch 5min for 37 ℃, add 0.025mol/L CaCl immediately 2Solution 0.1mL picks up counting simultaneously, when solution becomes turbid, stops timing, and this time is gallogen partial thromboplastin activationary time (APTT).Adding 0.1mL saline water and GST albumen simultaneously respectively replaces Rhipilin-1 not add the gallogen partial prothrombinase activationary time (APTT) of RhAP as blank determination.
2. result and analysis
2.1 crescent fan head tick anticoagulation molecule Rhipilin-1 expression of gene and purifying
Crescent fan head tick anticoagulation molecule Rhipilin-1 recombinant plasmid transformed is induced successful expression through IPTG in intestinal bacteria E.coli BL21.SDS-PAGE result shows, the GST albumen that empty plasmid pGEX-4T-1 expresses is 26kDa, and the GST-fusion rotein of expression of recombinant plasmid is 44kDa, big or small consistent with the expection recombinant protein.Further analysis revealed, the recombination fusion protein majority exists with the soluble proteins form, through GSTBind TMThe test kit purifying obtains purified recombinant Rhipilin-1 (Fig. 2).
2.2 reorganization Rhipilin-1 is to the influence of rabbit plasma recalcification time
The result is as shown in Figure 3; After adding crescent fan head tick anticoagulation molecule reorganization Rhipilin-1; The rabbit plasma recalcification time increases with concentration and prolongs; When crescent fan head tick anticoagulation molecule reorganization Rhipilin-1 concentration reaches 75nM when above, for the restraining effect significant difference of blood plasma agglutination, contrast reorganization GST all unrestraint blood plasma agglutination effects under the different concns condition; Saline water contrasts also unrestraint blood plasma agglutination effect, and the result shows that reorganization Rhipilin-1 has anticoagulation to rabbit plasma, and has concentration dependence characteristic.
2.3 reorganization Rhipilin-1 is to the influence of rabbit plasma partial prothrombinase activationary time
The experimental result of rabbit plasma partial prothrombinase activationary time (APTT) is as shown in Figure 4; Compare with reorganization GST with contrast saline water; When crescent fan head tick anticoagulation molecule reorganization Rhipilin-1 final concentration is that 15.625nM is when above; But significant prolongation rabbit plasma gallogen partial prothrombinase activationary time (APTT), and along with concentration to increase activationary time long more, explain that the anticoagulation of crescent fan head tick anticoagulation molecule reorganization Rhipilin-1 is fairly obvious and has concentration dependence characteristics.The experimental result of APTT shows that also reorganization Rhipilin-1 not only suppresses blood coagulation from endogenous blood coagulation system, also has the obvious suppression effect to the external source coagulation pathway.
Sequence table
< 110>China Agriculture Academe Shanghai Veterinary Institute
< 120>gene order of a kind of anticoagulation molecule Rhipilin-1 of hard tick and recombinant expressed
< 130>specification sheets, claims
<160>2
<170>PatentIn version 3.3
<210>1
<211>620
<212>DNA
< 213>nucleotide sequence of anticoagulation molecule Rhipilin-1
<400>1
aatattggaa aaacttcagc gagcagaaaa caaccaaagg caatgaagat tttacaatac 60
gcgctcttgg cttgtcttct cgtctcgata ttaggcgatg atgatgacga agaaaacgag 120
ggtgcggcgg ggagtgatga tgcgggcgca acgcctacag cactgtcgaa gccagcagcc 180
acttctgcgg aaggaaacac cgcagcaaaa aactcaggtg gtgacatcaa gcaaccgaaa 240
caagaactgc ccgaaccgtc ctcaaaaggc caaaagaaac cgagactacc caagagatgc 300
ttattcaagc cagaacaggg aaactgcgca ggttctcgtt tccttcctag atggtggtat 360
aacccagaaa ctgagagctg cgaaccattc acttatccag tgtgcaataa gaaaaacgaa 420
gcattcgtat catgtacact gtgcatgaac atgtgcatga ggaataagag gggcagggag 480
aaggctaaat ggattagaaa agtttgtaga aaaagtccga aagtaaaatc tggatgaatg 540
tagttggctc tgccacttct tctgccataa aatattcgaa aacatttgtt atgaataata 600
aaattatcaa aaaaaaaaaa 620
<210>2
<211>164
<212>PRT
< 213>tick anticoagulant molecule Rhipilin-1 aminoacid sequence
<400>2
Met Lys Ile Leu Gln Tyr Ala Leu Leu Ala Cys Leu Leu Val Ser Ile
1 5 10 15
Leu Gly Asp Asp Asp Asp Glu Glu Asn Glu Gly Ala Ala Gly Ser Asp
20 25 30
Asp Ala Gly Ala Thr Pro Thr Ala Leu Ser Lys Pro Ala Ala Thr Ser
35 40 45
Ala Glu Gly Asn Thr Ala Ala Lys Asn Ser Gly Gly Asp Ile Lys Gln
50 55 60
Pro Lys Gln Glu Leu Pro Glu Pro Ser Ser Lys Gly Gln Lys Lys Pro
65 70 75 80
Arg Leu Pro Lys Arg Cys Leu Phe Lys Pro Glu Gln Gly Asn Cys Ala
85 90 95
Gly Ser Arg Phe Leu Pro Arg Trp Trp Tyr Asn Pro Glu Thr Glu Ser
100 105 110
Cys Glu Pro Phe Thr Tyr Pro Val Cys Asn Lys Lys Asn Glu Ala Phe
115 120 125
Val Ser Cys Thr Leu Cys Met Asn Met Cys Met Arg Asn Lys Arg Gly
130 135 140
Arg Glu Lys Ala Lys Trp Ile Arg Lys Val Cys Arg Lys Ser Pro Lys
145 150 155 160
Val Lys Ser Gly

Claims (3)

1. crescent fan head tick anticoagulation molecule Rhipilin-1 gene order; It is characterized in that said full length gene is 620bp; Hold the signal sequence AATAAA that polyA and polyA are arranged 3 ', contain a complete ORFs, from the 43rd base to 536 base; 164 amino acid of encoding, its molecular weight is 18kDa; The signal peptide sequence that its proteins encoded has 18 amino acid to constitute at the N-end; Cut point is between the 18th and the 19th amino acid: from 139 amino acid of the 84th amino acid to the, and typical serpin Kunitz domain of predictive coding;
Nucleotide sequence and the corresponding amino acid sequence of said crescent fan head tick anticoagulation molecule Rhipilin-1 are following:
The nucleotide sequence of crescent fan head tick anticoagulation molecule Rhipilin-1:
aatattggaa aaacttcagc gagcagaaaa caaccaaagg caatgaagat tttacaatac 60
gcgctcttgg cttgtcttct cgtctcgata ttaggcgatg atgatgacga agaaaacgag 120
ggtgcggcgg ggagtgatga tgcgggcgca acgcctacag cactgtcgaa gccagcagcc 180
acttctgcgg aaggaaacac cgcagcaaaa aactcaggtg gtgacatcaa gcaaccgaaa 240
caagaactgc ccgaaccgtc ctcaaaaggc caaaagaaac cgagactacc caagagatgc 300
ttattcaagc cagaacaggg aaactgcgca ggttctcgtt tccttcctag atggtggtat 360
aacccagaaa ctgagagctg cgaaccattc acttatccag tgtgcaataa gaaaaacgaa 420
gcattcgtat catgtacact gtgcatgaac atgtgcatga ggaataagag gggcagggag 480
aaggctaaat ggattagaaa agtttgtaga aaaagtccga aagtaaaatc tggatgaatg 540
tagttggctc tgccacttct tctgccataa aatattcgaa aacatttgtt atgaataata 600
aaattatcaa aaaaaaaaaa 620
Crescent fan head tick tick anticoagulant molecule Rhipilin-1 aminoacid sequence:
Met Lys Ile Leu Gln Tyr Ala Leu Leu Ala Cys Leu Leu Val Ser Ile
1 5 10 15
Leu Gly Asp Asp Asp Asp Glu Glu Asn Glu Gly Ala Ala Gly Ser Asp
20 25 30
Asp Ala Gly Ala Thr Pro Thr Ala Leu Ser Lys Pro Ala Ala Thr Ser
35 40 45
Ala Glu Gly Asn Thr Ala Ala Lys Asn Ser Gly Gly Asp Ile Lys Gln
50 55 60
Pro Lys Gln Glu Leu Pro Glu Pro Ser Ser Lys Gly Gln Lys Lys Pro
65 70 75 80
Arg Leu Pro Lys Arg Cys Leu Phe Lys Pro Glu Gln Gly Asn Cys Ala
85 90 95
Gly Ser Arg Phe Leu Pro Arg Trp Trp Tyr Asn Pro Glu Thr Glu Ser
100 105 110
Cys Glu Pro Phe Thr Tyr Pro Val Cys Asn Lys Lys Asn Glu Ala Phe
115 120 125
Val Ser Cys Thr Leu Cys Met Asn Met Cys Met Arg Asn Lys Arg Gly
130 135 140
Arg Glu Lys Ala Lys Trp Ile Arg Lys Val Cys Arg Lys Ser Pro Lys
145 150 155 160
Val Lys Ser Gly。
2. the recombinant expression method of a kind of crescent fan head tick anticoagulation molecule Rhipilin-1 as claimed in claim 1 in intestinal bacteria; It is characterized in that; With the actual coding district subclone that does not comprise signal peptide sequence in prokaryotic expression carrier pGEX-4T-1; Make up recombinant expression plasmid pGEX-4T-1/Rhipilin-1, be transformed into after BL21 expresses bacterium, use the IPTG abduction delivering; The SDS-PAGE electrophoretic analysis shows that the reorganization gst fusion protein obtains to efficiently express, and the GST-fusion rotein is 44kDa, big or small consistent with the expection recombinant protein.
3. the application of a kind of crescent fan head tick anticoagulation molecule Rhipilin-1 as claimed in claim 1 in preparation anticoagulation biotechnological formulation.
CN 200910053692 2009-06-24 2009-06-24 Anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides, recombinant expression and application Expired - Fee Related CN101928710B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200910053692 CN101928710B (en) 2009-06-24 2009-06-24 Anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides, recombinant expression and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200910053692 CN101928710B (en) 2009-06-24 2009-06-24 Anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides, recombinant expression and application

Publications (2)

Publication Number Publication Date
CN101928710A CN101928710A (en) 2010-12-29
CN101928710B true CN101928710B (en) 2012-05-09

Family

ID=43368140

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200910053692 Expired - Fee Related CN101928710B (en) 2009-06-24 2009-06-24 Anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides, recombinant expression and application

Country Status (1)

Country Link
CN (1) CN101928710B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102153640A (en) * 2011-01-15 2011-08-17 中国农业科学院上海兽医研究所 Anticoagulation protein of tick and gene and application thereof
CN110790833B (en) * 2018-08-01 2022-07-15 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) Tick autophagy-associated protein molecule ATG5 and application thereof
CN112083172B (en) * 2020-09-17 2024-01-26 鄂尔多斯市中心医院(内蒙古自治区超声影像研究所) Method for screening protein with anticoagulant activity from tick cDNA library
CN114853883B (en) * 2022-05-06 2023-05-16 青海大学 Qinghai blood tick serine protease inhibitor and polyclonal antibody thereof
CN116410303B (en) * 2023-06-07 2023-09-12 鄂尔多斯市中心医院(内蒙古自治区超声影像研究所) Application of tick anticoagulant protein Qinghienin and encoding gene thereof in anticoagulation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1657617A (en) * 2004-02-18 2005-08-24 中国农业科学院上海家畜寄生虫病研究所 Clone, expression and anti-tick immanoprotection action of falcate rhipicephalus RhcA and RhcB genes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1657617A (en) * 2004-02-18 2005-08-24 中国农业科学院上海家畜寄生虫病研究所 Clone, expression and anti-tick immanoprotection action of falcate rhipicephalus RhcA and RhcB genes

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
向飞宇等.镰形扇头蜱唾液腺抑制消减杂交文库的构建和分析.《中国农业科学》.2006,第39卷(第11期),第2347-2353页. *
恭海燕等.镰形扇头蟀半饱血雌蝉cDNA文库的构建.《中国人兽共患病杂志》.2004,第20卷(第6期),第485-488页. *
王玉霞等.蜱功能基因研究进展.《动物医学进展》.2005,第26卷(第7期),第31-35页. *

Also Published As

Publication number Publication date
CN101928710A (en) 2010-12-29

Similar Documents

Publication Publication Date Title
Mu et al. Identification and characterization of a mannose-binding lectin from Nile tilapia (Oreochromis niloticus)
Maier et al. Characterisation of cathelicidin gene family members in divergent fish species
Bachère et al. The new insights into the oyster antimicrobial defense: Cellular, molecular and genetic view
Min et al. Salivary transcriptome of the North American medicinal leech, Macrobdella decora
CN101928710B (en) Anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides, recombinant expression and application
Francischetti et al. An insight into the salivary transcriptome and proteome of the soft tick and vector of epizootic bovine abortion, Ornithodoros coriaceus
Khalil et al. Full-length sequence, regulation and developmental studies of a second vitellogenin gene from the American dog tick, Dermacentor variabilis
Du et al. A double WAP domain (DWD)-containing protein with proteinase inhibitory activity in Chinese white shrimp, Fenneropenaeus chinensis
Portet et al. BgTEP: an antiprotease involved in innate immune sensing in Biomphalaria glabrata
Wang et al. Characterization and functional analysis of a novel C1q-domain-containing protein in Japanese flounder (Paralichthys olivaceus)
Zhang et al. Molecular cloning and characterization of a thioester-containing protein from Zhikong scallop Chlamys farreri
Dodds et al. Isolation and initial characterisation of complement components C3 and C4 of the nurse shark and the channel catfish
Chen et al. Characterization of the immune roles of cathepsin L in turbot (Scophthalmus maximus L.) mucosal immunity
Cui et al. A novel C1q-domain-containing protein from razor clam Sinonovacula constricta mediates G-bacterial agglutination as a pattern recognition receptor
Xiang et al. Characteristic and functional analysis of a ficolin-like protein from the oyster Crassostrea hongkongensis
Su et al. Molecular cloning and characterization of a short type peptidoglycan recognition protein (CfPGRP-S1) cDNA from Zhikong scallop Chlamys farreri
Wang et al. Two novel LRR and Ig domain-containing proteins from oyster Crassostrea gigas function as pattern recognition receptors and induce expression of cytokines
Ratzka et al. Molecular characterization of antimicrobial peptide genes of the carpenter ant Camponotus floridanus
Wang et al. An alpha-2 macroglobulin in the pearl oyster Pinctada fucata: Characterization and function in hemocyte phagocytosis of Vibrio alginolyticus
CN105273072B (en) The anticoagulant protein B26 and its gene of tick and application
Wang et al. Molecular diversity and evolution of defensins in the manila clam Ruditapes philippinarum
Luo et al. Characterization of a CD59 in orange-spotted grouper (Epinephelus coioides)
Shang-Guan et al. A C-type lectin with a single CRD from Onychostoma macrolepis mediates immune recognition against bacterial challenge
CN102816221A (en) Chicken E. tenella MA1 (EtMA1) gene, vector, recombinant strain, EtMA1 protein, EtMA1-Outside domain, and use of the EtMA1 protein and the EtMA1-Outside domain
JP2001515720A (en) β-defensin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120509

Termination date: 20180624

CF01 Termination of patent right due to non-payment of annual fee